会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • NOVEL SEMISYNTHETIC MACROLIDE ANTIBIOTICS OF THE AZALIDE SERIES
    • 亚氯酸盐系列的新型半胱氨酸抗体抗体
    • WO2004052904A3
    • 2004-09-02
    • PCT/HR0300062
    • 2003-12-10
    • PLIVA ISTRAZIVACKI INST D O OKUJUNDZIC NEDJELJKOBUKVIC KRAJACIC MIRJANABRAJSA KARMEN
    • KUJUNDZIC NEDJELJKOBUKVIC KRAJACIC MIRJANABRAJSA KARMEN
    • A61K31/70A61P31/04C07H17/00C07H17/08
    • C07H17/00
    • The invention relates to N"-substituted 9a-N-(N'-carbamoyl-gamma-aminopropyl), 9a--N-(N'-thiocarbamoyl-gamma-aminopropyl), 9a-N-[N'-((beta-cyanoethyl)-N'-carbamoyl-gamma -aminopropyl] and 9a-N-[N'-((beta-cyanoethyl)-N'-thiocarbamoyl-gamma-aminopropyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithromycin A and 5-0-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerithronolide A, novel semisynthetic macrolide antibiotics of the azalide series, of the general formula 1, wherein R represents H or cladinosyl moiety, R represents H or (beta-cyanoethyl moiety, R represents isopropyl, 1-naphtyl, 2-naphtyl, benzyl, 2-(trifluoromethyl)phenyl, 3-phenylpropyl, beta-phenylethyl, ethoxycarbonylmethyl, 1-(1-naphtyl)ethyl, 3,4,5-trimethoxyphenyl and 2,4-dichlorophenyl group, and X represents 0 and S, and their acceptable addition salts thereof with inorganic or organic acids, to the process for preparation of their pharmaceutical compositions as well as the use their compositions in the treatment of bacterial infections.
    • 本发明涉及N“ - 取代的9a-N-(N'-氨基甲酰基-γ-氨基丙基),9a-N-(N'-硫代氨基甲酰基-γ-氨基丙基),9a-N- [N' - ((β - 氰基乙基)-N'-氨基甲酰基-γ-氨基丙基]和9a-N- [N' - ((β-氰基乙基)-N'-硫代氨基甲酰基-γ-氨基丙基]衍生物的9-脱氧-9-二氢-9a- 氮杂-9a-高雪霉素A和5-0-去氨基-9-脱氧-9-二氢-9a-氮杂-9a-高丝氨酸新霉素A是通式1的氮杂类化合物的新型半合成大环内酯类抗生素,其中R表示H或 (β-氰基乙基部分,R 2表示异丙基,1-萘基,2-萘基,苄基,2-(三氟甲基)苯基,3-苯基丙基,β-苯基乙基,乙氧基羰基甲基, 1-(1-萘基)乙基,3,4,5-三甲氧基苯基和2,4-二氯苯基,X代表0和S,以及它们与无机或有机酸的可接受的加成盐,用于制备它们的 药物组合物以及在治疗中使用它们的组合物 细菌感染。
    • 9. 发明申请
    • N
    • N' - 取代的9a-N-(N'-氨基甲酰基-γ-氨基丙基),9a-N-(N' - 硫代氨基甲酰基-γ-氨基丙基),9a-N- [N' - ((β-氰基乙基) ' - 氨基甲酰基-γ-氨基丙基]和9-de的9a-N- [N' - (β-氰基乙基)-N'-硫代氨基甲酰基-γ-氨基丙基]衍生物
    • WO2004052904A2
    • 2004-06-24
    • PCT/HR2003/000062
    • 2003-12-10
    • PLIVA D.D.KUJUNDZIC, NedjeljkoBUKVIC, Krajacic, MirjanaBRAJSA, Karmen
    • KUJUNDZIC, NedjeljkoBUKVIC, Krajacic, MirjanaBRAJSA, Karmen
    • C07H17/00
    • C07H17/00
    • The invention relates to N"-substituted 9a-N-(N'-carbamoyl-γ-aminopropyl), 9a­-N-(N'-thiocarbamoyl-γ-aminopropyl), 9a-N-[N'-((β-cyanoethyl)-N'-carbamoyl-γ­-aminopropyl] and 9a-N-[N'-((β-cyanoethyl)-N'-thiocarbamoyl-γ-aminopropyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithromycin A and 5-0­-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerithronolide A, novel semi­synthetic macrolide antibiotics of the azalide series, of the general formula 1, wherein R represents H or cladinosyl moiety, R 1 represents H or (β-cyanoethyl moiety, R 2 represents isopropyl, 1-naphtyl, 2-naphtyl, benzyl, 2­-(trifluoromethyl)phenyl, 3-phenylpropyl, β-phenylethyl, ethoxycarbonyl­methyl, 1-(1-naphtyl)ethyl, 3,4,5-trimethoxyphenyl and 2,4-dichlorophenyl group, and X represents 0 and S, and their acceptable addition salts thereof with inorganic or organic acids, to the process for preparation of their pharmaceutical compositions as well as the use their compositions in the treatment of bacterial infections.
    • 本发明涉及N“ - 取代的9a-N-(N'-氨基甲酰基-γ-氨基丙基),9a-N-(N'-硫代氨基甲酰基-γ-氨基丙基),9a-N- [N' - ((β- 氰基乙基)-N'-氨基甲酰基-γ-氨基丙基]和9-9-氧代-9-二氢-9a-氮杂-9α-〔N' - ((β-氰乙基)-N'-硫代氨基甲酰基-γ-氨丙基] -9a-高雪霉素A和5-0-去氨基-9-脱氧-9-二氢-9a-氮杂-9a-高丝氨酸内酯A是通式1的氮杂类化合物的新型半合成大环内酯类抗生素,其中R代表H或克棱糖基 部分,R 1表示H或(β-氰乙基部分,R 2表示异丙基,1-萘基,2-萘基,苄基,2-(三氟甲基)苯基,3-苯基丙基,β-苯基乙基,乙氧基羰基甲基,1 - (1-萘基)乙基,3,4,5-三甲氧基苯基和2,4-二氯苯基,X表示0和S,以及它们与无机或有机酸的可接受的加成盐,用于制备其药物 组合物以及其组成 治疗细菌感染。